Jianwen Li
Wuhan, 430030, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Handelin inhibits osteoclastogenesis and bone loss by targeting lipocalin-2 and restoring autophagy to suppress NF-κB signaling.
Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology
Published: November 30, 2025
Daucosterol alleviates osteoarthritis by targeting chondrocyte senescence via inhibiting of the JNK pathway.
Journal: International immunopharmacology
Published: October 14, 2025
CORM-3 mitigates osteoarthritis by anti-inflammation and enhancing autophagy via inhibiting MAPK and mTOR pathways.
Journal: International immunopharmacology
Published: May 05, 2025
Development and validation of a novel glucolipid metabolism-related nomogram to enhance the predictive performance for osteoporosis complications in prediabetic and diabetic patients.
Journal: Lipids in health and disease
Published: January 02, 2025
Blocking the LRH-1/LCN2 axis by ML-180, an LRH-1 inverse agonist, ameliorates osteoarthritis via inhibiting the MAPK pathway.
Journal: Biochemical pharmacology
Published: November 17, 2024
Comparison of the MIPPO technique and the modified Stoppa approach in the treatment of unstable anterior pelvic ring injuries: a retrospective cohort study.
Journal: BMC musculoskeletal disorders
Published: June 26, 2024
MRI spectrum of avascular necrosis of femoral head in patients treated for COVID-19.
Journal: Hip international : the journal of clinical and experimental research on hip pathology and therapy
Published: March 08, 2024
Vinpocetine inhibits RANKL-induced osteoclastogenesis and attenuates ovariectomy-induced bone loss.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: October 30, 2019
Showing 1-9 of 9
Last Updated: 09/26/2026